BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Muneer A. The Discovery of Clinically Applicable Biomarkers for Bipolar Disorder: A Review of Candidate and Proteomic Approaches. Chonnam Med J 2020;56:166-79. [PMID: 33014755 DOI: 10.4068/cmj.2020.56.3.166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Engelke R, Ouanes S, Ghuloum S, Chamali R, Kiwan N, Sarwath H, Schmidt F, Suhre K, Al-Amin H. Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls. Front Psychiatry 2022;13:809071. [PMID: 35546954 DOI: 10.3389/fpsyt.2022.809071] [Reference Citation Analysis]
2 Marques AP, Resende R, Silva DF, Batista M, Pereira D, Wildenberg B, Morais S, Macedo A, Pais C, Melo JB, Madeira N, Pereira CF. Mitochondrial Alterations in Fibroblasts of Early Stage Bipolar Disorder Patients. Biomedicines 2021;9:522. [PMID: 34066918 DOI: 10.3390/biomedicines9050522] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]